Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Development of Itraconazole Tablets Containing Viscous KinetiSol Solid Dispersions: In Vitro and In Vivo Analysis in Dogs.

Keen JM, LaFountaine JS, Hughey JR, Miller DA, McGinity JW.

AAPS PharmSciTech. 2018 Jul;19(5):1998-2008. doi: 10.1208/s12249-017-0903-1. Epub 2017 Nov 30.

PMID:
29192405
2.

In Vitro-In Vivo Correlations of Carbamazepine Nanodispersions for Application in Formulation Development.

Warnken Z, Puppolo M, Hughey J, Duarte I, Jansen-Varnum S.

J Pharm Sci. 2018 Jan;107(1):453-465. doi: 10.1016/j.xphs.2017.10.014. Epub 2017 Oct 16.

PMID:
29045883
3.

Biomimetic Dissolution: A Tool to Predict Amorphous Solid Dispersion Performance.

Puppolo MM, Hughey JR, Dillon T, Storey D, Jansen-Varnum S.

AAPS PharmSciTech. 2017 Nov;18(8):2841-2853. doi: 10.1208/s12249-017-0783-4. Epub 2017 May 30.

PMID:
28560506
4.

Continuous twin screw melt granulation of glyceryl behenate: Development of controlled release tramadol hydrochloride tablets for improved safety.

Keen JM, Foley CJ, Hughey JR, Bennett RC, Jannin V, Rosiaux Y, Marchaud D, McGinity JW.

Int J Pharm. 2015 Jun 20;487(1-2):72-80. doi: 10.1016/j.ijpharm.2015.03.058. Epub 2015 Mar 31.

PMID:
25839417
5.

Effect of tablet structure on controlled release from supersaturating solid dispersions containing glyceryl behenate.

Keen JM, Hughey JR, Bennett RC, Jannin V, Rosiaux Y, Marchaud D, McGinity JW.

Mol Pharm. 2015 Jan 5;12(1):120-6. doi: 10.1021/mp500480y. Epub 2014 Nov 25.

PMID:
25347621
6.

The incorporation of low-substituted hydroxypropyl cellulose into solid dispersion systems.

Hughey JR, Keen JM, Bennett RC, Obara S, McGinity JW.

Drug Dev Ind Pharm. 2015;41(8):1294-301. doi: 10.3109/03639045.2014.947508. Epub 2014 Aug 18.

PMID:
25133663
7.

Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract.

Bennett RC, Brough C, Miller DA, O'Donnell KP, Keen JM, Hughey JR, Williams RO 3rd, McGinity JW.

Drug Dev Ind Pharm. 2015 Mar;41(3):382-97. doi: 10.3109/03639045.2013.866142. Epub 2013 Dec 16.

PMID:
24329130
8.

The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions.

Hughey JR, Keen JM, Miller DA, Kolter K, Langley N, McGinity JW.

Eur J Pharm Sci. 2013 Mar 12;48(4-5):758-66. doi: 10.1016/j.ejps.2013.01.004. Epub 2013 Jan 21.

PMID:
23348153
9.

Preparation and characterization of fusion processed solid dispersions containing a viscous thermally labile polymeric carrier.

Hughey JR, Keen JM, Miller DA, Brough C, McGinity JW.

Int J Pharm. 2012 Nov 15;438(1-2):11-9. doi: 10.1016/j.ijpharm.2012.08.032. Epub 2012 Aug 31.

PMID:
22960321
10.

Thermal processing of a poorly water-soluble drug substance exhibiting a high melting point: the utility of KinetiSol® Dispersing.

Hughey JR, Keen JM, Brough C, Saeger S, McGinity JW.

Int J Pharm. 2011 Oct 31;419(1-2):222-30. doi: 10.1016/j.ijpharm.2011.08.007. Epub 2011 Aug 16.

PMID:
21864663
11.

Use of highly compressible Ceolus™ microcrystalline cellulose for improved dosage form properties containing a hydrophilic solid dispersion.

Dinunzio JC, Schilling SU, Coney AW, Hughey JR, Kaneko N, McGinity JW.

Drug Dev Ind Pharm. 2012 Feb;38(2):180-9. doi: 10.3109/03639045.2011.595415. Epub 2011 Jul 21.

PMID:
21774741
12.

Dissolution enhancement of a drug exhibiting thermal and acidic decomposition characteristics by fusion processing: a comparative study of hot melt extrusion and KinetiSol dispersing.

Hughey JR, DiNunzio JC, Bennett RC, Brough C, Miller DA, Ma H, Williams RO 3rd, McGinity JW.

AAPS PharmSciTech. 2010 Jun;11(2):760-74. doi: 10.1208/s12249-010-9431-y. Epub 2010 May 5.

13.

Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol Dispersing.

DiNunzio JC, Hughey JR, Brough C, Miller DA, Williams RO 3rd, McGinity JW.

Drug Dev Ind Pharm. 2010 Sep;36(9):1064-78. doi: 10.3109/03639041003652973.

PMID:
20334539
14.

Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing.

Dinunzio JC, Brough C, Hughey JR, Miller DA, Williams RO 3rd, McGinity JW.

Eur J Pharm Biopharm. 2010 Feb;74(2):340-51. doi: 10.1016/j.ejpb.2009.09.007. Epub 2009 Oct 7.

PMID:
19818402

Supplemental Content

Loading ...
Support Center